Stocksigma LogoStocksigma Logo

Bharat Parenterals Approves ₹139 Crore Preferential Issue to Institutional Investors

Bharat Parenterals' board approved a preferential allotment of up to 9,12,759 equity shares (face value ₹10) at ₹1,522.85 per share, raising ₹138.99 crore

Bharat Parenterals Approves ₹139 Crore Preferential Issue to Institutional Investors

Bharat Parenterals Ltd · Outcome · 29 Sept 2026, 9:52 pm

Bharat Parenterals Approves ₹139 Crore Preferential Issue to Institutional Investors Bharat Parenterals' board approved a preferential allotment of up to 9,12,759 equity shares (face value ₹10) at ₹1,522.85 per share, raising ₹138.99 crore from 15 non-promoter investors, including WhiteOak Capital entities and Aurum Rising India Fund. Post-allotment, these investors will hold a combined 12.11% stake. The board also approved investing in or providing loans to subsidiaries for project development. An Extraordinary General Meeting is scheduled for 23rd Oct'26 to obtain shareholder approval for the proposed issue.

Original exchange filing (PDF)

More announcements from Bharat Parenterals Ltd

All Bharat Parenterals Ltd announcements